nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2C19—Teniposide—lymphatic system cancer	0.111	0.546	CbGbCtD
Formoterol—CYP2C9—Teniposide—lymphatic system cancer	0.0925	0.454	CbGbCtD
Formoterol—Arthralgia—Fludarabine—lymphatic system cancer	0.00257	0.00323	CcSEcCtD
Formoterol—Myalgia—Fludarabine—lymphatic system cancer	0.00257	0.00323	CcSEcCtD
Formoterol—Discomfort—Fludarabine—lymphatic system cancer	0.00254	0.00319	CcSEcCtD
Formoterol—Hyperglycaemia—Carmustine—lymphatic system cancer	0.0025	0.00314	CcSEcCtD
Formoterol—Dyspnoea—Teniposide—lymphatic system cancer	0.0025	0.00314	CcSEcCtD
Formoterol—Oedema—Fludarabine—lymphatic system cancer	0.00246	0.00309	CcSEcCtD
Formoterol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00246	0.00309	CcSEcCtD
Formoterol—Infection—Fludarabine—lymphatic system cancer	0.00245	0.00307	CcSEcCtD
Formoterol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00242	0.00304	CcSEcCtD
Formoterol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00242	0.00303	CcSEcCtD
Formoterol—Urinary tract infection—Carmustine—lymphatic system cancer	0.0024	0.00302	CcSEcCtD
Formoterol—Rash—Mechlorethamine—lymphatic system cancer	0.0024	0.00301	CcSEcCtD
Formoterol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.0024	0.00301	CcSEcCtD
Formoterol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0024	0.00301	CcSEcCtD
Formoterol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00233	0.00292	CcSEcCtD
Formoterol—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00233	0.00292	CcSEcCtD
Formoterol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00231	0.00291	CcSEcCtD
Formoterol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00231	0.0029	CcSEcCtD
Formoterol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00229	0.00288	CcSEcCtD
Formoterol—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.00228	0.00287	CcSEcCtD
Formoterol—Skin discolouration—Methotrexate—lymphatic system cancer	0.00227	0.00285	CcSEcCtD
Formoterol—Bone disorder—Methotrexate—lymphatic system cancer	0.00227	0.00285	CcSEcCtD
Formoterol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00227	0.00285	CcSEcCtD
Formoterol—Nausea—Mechlorethamine—lymphatic system cancer	0.00226	0.00284	CcSEcCtD
Formoterol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00225	0.00283	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00224	0.00282	CcSEcCtD
Formoterol—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00223	0.00281	CcSEcCtD
Formoterol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00223	0.00281	CcSEcCtD
Formoterol—Urticaria—Teniposide—lymphatic system cancer	0.00223	0.0028	CcSEcCtD
Formoterol—Herpes simplex—Methotrexate—lymphatic system cancer	0.00222	0.00279	CcSEcCtD
Formoterol—Abdominal pain—Teniposide—lymphatic system cancer	0.00222	0.00278	CcSEcCtD
Formoterol—Body temperature increased—Teniposide—lymphatic system cancer	0.00222	0.00278	CcSEcCtD
Formoterol—Dyspnoea—Fludarabine—lymphatic system cancer	0.0022	0.00276	CcSEcCtD
Formoterol—Haematuria—Mitoxantrone—lymphatic system cancer	0.00219	0.00275	CcSEcCtD
Formoterol—Oedema peripheral—Carmustine—lymphatic system cancer	0.00219	0.00275	CcSEcCtD
Formoterol—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00218	0.00274	CcSEcCtD
Formoterol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00217	0.00272	CcSEcCtD
Formoterol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00216	0.00271	CcSEcCtD
Formoterol—Visual impairment—Carmustine—lymphatic system cancer	0.00214	0.00269	CcSEcCtD
Formoterol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00213	0.00267	CcSEcCtD
Formoterol—Fatigue—Fludarabine—lymphatic system cancer	0.00212	0.00267	CcSEcCtD
Formoterol—Inflammation—Methotrexate—lymphatic system cancer	0.00211	0.00265	CcSEcCtD
Formoterol—Constipation—Fludarabine—lymphatic system cancer	0.00211	0.00265	CcSEcCtD
Formoterol—Pain—Fludarabine—lymphatic system cancer	0.00211	0.00265	CcSEcCtD
Formoterol—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00209	0.00263	CcSEcCtD
Formoterol—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00208	0.00261	CcSEcCtD
Formoterol—Urethral disorder—Vincristine—lymphatic system cancer	0.00208	0.00261	CcSEcCtD
Formoterol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00207	0.0026	CcSEcCtD
Formoterol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00207	0.00259	CcSEcCtD
Formoterol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00205	0.00258	CcSEcCtD
Formoterol—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00205	0.00257	CcSEcCtD
Formoterol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00203	0.00255	CcSEcCtD
Formoterol—Asthenia—Teniposide—lymphatic system cancer	0.00201	0.00253	CcSEcCtD
Formoterol—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.002	0.00251	CcSEcCtD
Formoterol—Melaena—Methotrexate—lymphatic system cancer	0.002	0.00251	CcSEcCtD
Formoterol—Malaise—Bleomycin—lymphatic system cancer	0.002	0.00251	CcSEcCtD
Formoterol—Pruritus—Teniposide—lymphatic system cancer	0.00198	0.00249	CcSEcCtD
Formoterol—Arrhythmia—Carmustine—lymphatic system cancer	0.00198	0.00249	CcSEcCtD
Formoterol—Cystitis—Methotrexate—lymphatic system cancer	0.00198	0.00248	CcSEcCtD
Formoterol—Cardiac disorder—Vincristine—lymphatic system cancer	0.00197	0.00247	CcSEcCtD
Formoterol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00195	0.00245	CcSEcCtD
Formoterol—Mental disorder—Carmustine—lymphatic system cancer	0.00194	0.00244	CcSEcCtD
Formoterol—Malnutrition—Carmustine—lymphatic system cancer	0.00193	0.00243	CcSEcCtD
Formoterol—Cough—Bleomycin—lymphatic system cancer	0.00193	0.00243	CcSEcCtD
Formoterol—Diarrhoea—Teniposide—lymphatic system cancer	0.00192	0.00241	CcSEcCtD
Formoterol—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00191	0.0024	CcSEcCtD
Formoterol—Chest pain—Bleomycin—lymphatic system cancer	0.00188	0.00237	CcSEcCtD
Formoterol—Myalgia—Bleomycin—lymphatic system cancer	0.00188	0.00237	CcSEcCtD
Formoterol—Back pain—Carmustine—lymphatic system cancer	0.00187	0.00235	CcSEcCtD
Formoterol—Discomfort—Bleomycin—lymphatic system cancer	0.00186	0.00234	CcSEcCtD
Formoterol—Mental disorder—Vincristine—lymphatic system cancer	0.00186	0.00233	CcSEcCtD
Formoterol—Neoplasm—Methotrexate—lymphatic system cancer	0.00185	0.00232	CcSEcCtD
Formoterol—Bladder pain—Methotrexate—lymphatic system cancer	0.00185	0.00232	CcSEcCtD
Formoterol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00184	0.00231	CcSEcCtD
Formoterol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00182	0.00228	CcSEcCtD
Formoterol—Tremor—Carmustine—lymphatic system cancer	0.00181	0.00227	CcSEcCtD
Formoterol—Oedema—Bleomycin—lymphatic system cancer	0.00181	0.00227	CcSEcCtD
Formoterol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00181	0.00227	CcSEcCtD
Formoterol—Infection—Bleomycin—lymphatic system cancer	0.00179	0.00225	CcSEcCtD
Formoterol—Back pain—Vincristine—lymphatic system cancer	0.00178	0.00224	CcSEcCtD
Formoterol—Vomiting—Teniposide—lymphatic system cancer	0.00178	0.00224	CcSEcCtD
Formoterol—Agitation—Carmustine—lymphatic system cancer	0.00178	0.00223	CcSEcCtD
Formoterol—Asthenia—Fludarabine—lymphatic system cancer	0.00177	0.00222	CcSEcCtD
Formoterol—Rash—Teniposide—lymphatic system cancer	0.00177	0.00222	CcSEcCtD
Formoterol—Dermatitis—Teniposide—lymphatic system cancer	0.00177	0.00222	CcSEcCtD
Formoterol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00176	0.00221	CcSEcCtD
Formoterol—Headache—Teniposide—lymphatic system cancer	0.00176	0.00221	CcSEcCtD
Formoterol—Pruritus—Fludarabine—lymphatic system cancer	0.00174	0.00219	CcSEcCtD
Formoterol—Back pain—Mitoxantrone—lymphatic system cancer	0.00174	0.00218	CcSEcCtD
Formoterol—Agitation—Vincristine—lymphatic system cancer	0.00169	0.00213	CcSEcCtD
Formoterol—Hypotension—Bleomycin—lymphatic system cancer	0.00169	0.00212	CcSEcCtD
Formoterol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00169	0.00212	CcSEcCtD
Formoterol—Hypertension—Carmustine—lymphatic system cancer	0.00167	0.00209	CcSEcCtD
Formoterol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00167	0.00209	CcSEcCtD
Formoterol—Nausea—Teniposide—lymphatic system cancer	0.00167	0.00209	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00165	0.00207	CcSEcCtD
Formoterol—Chest pain—Carmustine—lymphatic system cancer	0.00164	0.00207	CcSEcCtD
Formoterol—Myalgia—Carmustine—lymphatic system cancer	0.00164	0.00207	CcSEcCtD
Formoterol—Anxiety—Carmustine—lymphatic system cancer	0.00164	0.00206	CcSEcCtD
Formoterol—Malaise—Mitoxantrone—lymphatic system cancer	0.00162	0.00203	CcSEcCtD
Formoterol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00161	0.00202	CcSEcCtD
Formoterol—Hypertension—Vincristine—lymphatic system cancer	0.00159	0.002	CcSEcCtD
Formoterol—Oedema—Carmustine—lymphatic system cancer	0.00158	0.00198	CcSEcCtD
Formoterol—Myalgia—Vincristine—lymphatic system cancer	0.00157	0.00197	CcSEcCtD
Formoterol—Cough—Mitoxantrone—lymphatic system cancer	0.00157	0.00197	CcSEcCtD
Formoterol—Infection—Carmustine—lymphatic system cancer	0.00157	0.00197	CcSEcCtD
Formoterol—Vomiting—Fludarabine—lymphatic system cancer	0.00157	0.00197	CcSEcCtD
Formoterol—Rash—Fludarabine—lymphatic system cancer	0.00155	0.00195	CcSEcCtD
Formoterol—Dermatitis—Fludarabine—lymphatic system cancer	0.00155	0.00195	CcSEcCtD
Formoterol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00155	0.00195	CcSEcCtD
Formoterol—Pain—Bleomycin—lymphatic system cancer	0.00154	0.00194	CcSEcCtD
Formoterol—Headache—Fludarabine—lymphatic system cancer	0.00154	0.00194	CcSEcCtD
Formoterol—Tachycardia—Carmustine—lymphatic system cancer	0.00154	0.00193	CcSEcCtD
Formoterol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00153	0.00192	CcSEcCtD
Formoterol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00153	0.00192	CcSEcCtD
Formoterol—Myalgia—Mitoxantrone—lymphatic system cancer	0.00153	0.00192	CcSEcCtD
Formoterol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00152	0.00191	CcSEcCtD
Formoterol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00151	0.0019	CcSEcCtD
Formoterol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00151	0.00189	CcSEcCtD
Formoterol—Oedema—Vincristine—lymphatic system cancer	0.00151	0.00189	CcSEcCtD
Formoterol—Infection—Vincristine—lymphatic system cancer	0.0015	0.00188	CcSEcCtD
Formoterol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00149	0.00187	CcSEcCtD
Formoterol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00148	0.00185	CcSEcCtD
Formoterol—Hypotension—Carmustine—lymphatic system cancer	0.00147	0.00185	CcSEcCtD
Formoterol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00147	0.00184	CcSEcCtD
Formoterol—Oedema—Mitoxantrone—lymphatic system cancer	0.00147	0.00184	CcSEcCtD
Formoterol—Nausea—Fludarabine—lymphatic system cancer	0.00146	0.00184	CcSEcCtD
Formoterol—Infection—Mitoxantrone—lymphatic system cancer	0.00146	0.00183	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00144	0.0018	CcSEcCtD
Formoterol—Urticaria—Bleomycin—lymphatic system cancer	0.00144	0.0018	CcSEcCtD
Formoterol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00143	0.0018	CcSEcCtD
Formoterol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00143	0.00179	CcSEcCtD
Formoterol—Insomnia—Carmustine—lymphatic system cancer	0.00143	0.00179	CcSEcCtD
Formoterol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00142	0.00179	CcSEcCtD
Formoterol—Hypotension—Vincristine—lymphatic system cancer	0.00141	0.00177	CcSEcCtD
Formoterol—Dyspnoea—Carmustine—lymphatic system cancer	0.00141	0.00177	CcSEcCtD
Formoterol—Somnolence—Carmustine—lymphatic system cancer	0.0014	0.00176	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00137	0.00172	CcSEcCtD
Formoterol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00137	0.00172	CcSEcCtD
Formoterol—Insomnia—Vincristine—lymphatic system cancer	0.00136	0.00171	CcSEcCtD
Formoterol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00136	0.00171	CcSEcCtD
Formoterol—Pain—Carmustine—lymphatic system cancer	0.00135	0.00169	CcSEcCtD
Formoterol—Constipation—Carmustine—lymphatic system cancer	0.00135	0.00169	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00134	0.00168	CcSEcCtD
Formoterol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00133	0.00167	CcSEcCtD
Formoterol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00131	0.00164	CcSEcCtD
Formoterol—Somnolence—Mitoxantrone—lymphatic system cancer	0.0013	0.00164	CcSEcCtD
Formoterol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0013	0.00163	CcSEcCtD
Formoterol—Feeling abnormal—Carmustine—lymphatic system cancer	0.0013	0.00163	CcSEcCtD
Formoterol—Fatigue—Vincristine—lymphatic system cancer	0.0013	0.00163	CcSEcCtD
Formoterol—Asthenia—Bleomycin—lymphatic system cancer	0.0013	0.00163	CcSEcCtD
Formoterol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00129	0.00162	CcSEcCtD
Formoterol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00129	0.00162	CcSEcCtD
Formoterol—Constipation—Vincristine—lymphatic system cancer	0.00129	0.00162	CcSEcCtD
Formoterol—Pain—Vincristine—lymphatic system cancer	0.00129	0.00162	CcSEcCtD
Formoterol—Asthma—Methotrexate—lymphatic system cancer	0.00128	0.00161	CcSEcCtD
Formoterol—Pruritus—Bleomycin—lymphatic system cancer	0.00128	0.0016	CcSEcCtD
Formoterol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00126	0.00159	CcSEcCtD
Formoterol—Pain—Mitoxantrone—lymphatic system cancer	0.00125	0.00157	CcSEcCtD
Formoterol—Constipation—Mitoxantrone—lymphatic system cancer	0.00125	0.00157	CcSEcCtD
Formoterol—Abdominal pain—Carmustine—lymphatic system cancer	0.00125	0.00157	CcSEcCtD
Formoterol—Body temperature increased—Carmustine—lymphatic system cancer	0.00125	0.00157	CcSEcCtD
Formoterol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00123	0.00155	CcSEcCtD
Formoterol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00121	0.00152	CcSEcCtD
Formoterol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0012	0.00151	CcSEcCtD
Formoterol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00119	0.0015	CcSEcCtD
Formoterol—Body temperature increased—Vincristine—lymphatic system cancer	0.00119	0.00149	CcSEcCtD
Formoterol—Abdominal pain—Vincristine—lymphatic system cancer	0.00119	0.00149	CcSEcCtD
Formoterol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00116	0.00146	CcSEcCtD
Formoterol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00116	0.00146	CcSEcCtD
Formoterol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00116	0.00146	CcSEcCtD
Formoterol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00116	0.00146	CcSEcCtD
Formoterol—Vomiting—Bleomycin—lymphatic system cancer	0.00115	0.00144	CcSEcCtD
Formoterol—Rash—Bleomycin—lymphatic system cancer	0.00114	0.00143	CcSEcCtD
Formoterol—Dermatitis—Bleomycin—lymphatic system cancer	0.00114	0.00143	CcSEcCtD
Formoterol—Asthenia—Carmustine—lymphatic system cancer	0.00113	0.00142	CcSEcCtD
Formoterol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00111	0.0014	CcSEcCtD
Formoterol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00111	0.00139	CcSEcCtD
Formoterol—Haematuria—Methotrexate—lymphatic system cancer	0.00109	0.00137	CcSEcCtD
Formoterol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00108	0.00136	CcSEcCtD
Formoterol—Asthenia—Vincristine—lymphatic system cancer	0.00108	0.00136	CcSEcCtD
Formoterol—Diarrhoea—Carmustine—lymphatic system cancer	0.00108	0.00135	CcSEcCtD
Formoterol—Nausea—Bleomycin—lymphatic system cancer	0.00107	0.00135	CcSEcCtD
Formoterol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00105	0.00132	CcSEcCtD
Formoterol—Dizziness—Carmustine—lymphatic system cancer	0.00104	0.00131	CcSEcCtD
Formoterol—Diarrhoea—Vincristine—lymphatic system cancer	0.00103	0.00129	CcSEcCtD
Formoterol—Pharyngitis—Methotrexate—lymphatic system cancer	0.00102	0.00128	CcSEcCtD
Formoterol—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00102	0.00127	CcSEcCtD
Formoterol—Urethral disorder—Methotrexate—lymphatic system cancer	0.00101	0.00127	CcSEcCtD
Formoterol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.001	0.00126	CcSEcCtD
Formoterol—Vomiting—Carmustine—lymphatic system cancer	0.001	0.00126	CcSEcCtD
Formoterol—Dizziness—Vincristine—lymphatic system cancer	0.000995	0.00125	CcSEcCtD
Formoterol—Rash—Carmustine—lymphatic system cancer	0.000994	0.00125	CcSEcCtD
Formoterol—Dermatitis—Carmustine—lymphatic system cancer	0.000993	0.00125	CcSEcCtD
Formoterol—Visual impairment—Methotrexate—lymphatic system cancer	0.000991	0.00124	CcSEcCtD
Formoterol—Headache—Carmustine—lymphatic system cancer	0.000988	0.00124	CcSEcCtD
Formoterol—Vomiting—Vincristine—lymphatic system cancer	0.000957	0.0012	CcSEcCtD
Formoterol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000954	0.0012	CcSEcCtD
Formoterol—Rash—Vincristine—lymphatic system cancer	0.000949	0.00119	CcSEcCtD
Formoterol—Dermatitis—Vincristine—lymphatic system cancer	0.000948	0.00119	CcSEcCtD
Formoterol—Headache—Vincristine—lymphatic system cancer	0.000943	0.00118	CcSEcCtD
Formoterol—Nausea—Carmustine—lymphatic system cancer	0.000937	0.00118	CcSEcCtD
Formoterol—Vomiting—Mitoxantrone—lymphatic system cancer	0.000932	0.00117	CcSEcCtD
Formoterol—Immune system disorder—Methotrexate—lymphatic system cancer	0.000929	0.00117	CcSEcCtD
Formoterol—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000927	0.00116	CcSEcCtD
Formoterol—Rash—Mitoxantrone—lymphatic system cancer	0.000924	0.00116	CcSEcCtD
Formoterol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000923	0.00116	CcSEcCtD
Formoterol—Headache—Mitoxantrone—lymphatic system cancer	0.000918	0.00115	CcSEcCtD
Formoterol—Mental disorder—Methotrexate—lymphatic system cancer	0.000901	0.00113	CcSEcCtD
Formoterol—Malnutrition—Methotrexate—lymphatic system cancer	0.000895	0.00112	CcSEcCtD
Formoterol—Nausea—Vincristine—lymphatic system cancer	0.000894	0.00112	CcSEcCtD
Formoterol—Dysgeusia—Methotrexate—lymphatic system cancer	0.000876	0.0011	CcSEcCtD
Formoterol—Nausea—Mitoxantrone—lymphatic system cancer	0.000871	0.00109	CcSEcCtD
Formoterol—Back pain—Methotrexate—lymphatic system cancer	0.000866	0.00109	CcSEcCtD
Formoterol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00083	0.00104	CcSEcCtD
Formoterol—Malaise—Methotrexate—lymphatic system cancer	0.000807	0.00101	CcSEcCtD
Formoterol—Cough—Methotrexate—lymphatic system cancer	0.000781	0.000981	CcSEcCtD
Formoterol—Chest pain—Methotrexate—lymphatic system cancer	0.000762	0.000957	CcSEcCtD
Formoterol—Myalgia—Methotrexate—lymphatic system cancer	0.000762	0.000957	CcSEcCtD
Formoterol—Arthralgia—Methotrexate—lymphatic system cancer	0.000762	0.000957	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000757	0.00095	CcSEcCtD
Formoterol—Discomfort—Methotrexate—lymphatic system cancer	0.000753	0.000945	CcSEcCtD
Formoterol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00073	0.000917	CcSEcCtD
Formoterol—Infection—Methotrexate—lymphatic system cancer	0.000726	0.000911	CcSEcCtD
Formoterol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000716	0.000899	CcSEcCtD
Formoterol—Skin disorder—Methotrexate—lymphatic system cancer	0.000709	0.000891	CcSEcCtD
Formoterol—Hypotension—Methotrexate—lymphatic system cancer	0.000683	0.000857	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000665	0.000836	CcSEcCtD
Formoterol—Insomnia—Methotrexate—lymphatic system cancer	0.000661	0.00083	CcSEcCtD
Formoterol—Dyspnoea—Methotrexate—lymphatic system cancer	0.000651	0.000818	CcSEcCtD
Formoterol—Somnolence—Methotrexate—lymphatic system cancer	0.000649	0.000815	CcSEcCtD
Formoterol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000643	0.000807	CcSEcCtD
Formoterol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000631	0.000792	CcSEcCtD
Formoterol—Fatigue—Methotrexate—lymphatic system cancer	0.00063	0.000791	CcSEcCtD
Formoterol—Pain—Methotrexate—lymphatic system cancer	0.000625	0.000784	CcSEcCtD
Formoterol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000602	0.000756	CcSEcCtD
Formoterol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000597	0.00075	CcSEcCtD
Formoterol—Urticaria—Methotrexate—lymphatic system cancer	0.00058	0.000729	CcSEcCtD
Formoterol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000577	0.000725	CcSEcCtD
Formoterol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000577	0.000725	CcSEcCtD
Formoterol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000538	0.000676	CcSEcCtD
Formoterol—Asthenia—Methotrexate—lymphatic system cancer	0.000524	0.000658	CcSEcCtD
Formoterol—Pruritus—Methotrexate—lymphatic system cancer	0.000517	0.000649	CcSEcCtD
Formoterol—Diarrhoea—Methotrexate—lymphatic system cancer	0.0005	0.000628	CcSEcCtD
Formoterol—Dizziness—Methotrexate—lymphatic system cancer	0.000483	0.000607	CcSEcCtD
Formoterol—Vomiting—Methotrexate—lymphatic system cancer	0.000464	0.000583	CcSEcCtD
Formoterol—Rash—Methotrexate—lymphatic system cancer	0.000461	0.000578	CcSEcCtD
Formoterol—Dermatitis—Methotrexate—lymphatic system cancer	0.00046	0.000578	CcSEcCtD
Formoterol—Headache—Methotrexate—lymphatic system cancer	0.000458	0.000575	CcSEcCtD
Formoterol—Nausea—Methotrexate—lymphatic system cancer	0.000434	0.000545	CcSEcCtD
